Molecular Vision: Knight, Mol Vis 2022; 28:257-268. Table 1

Table 1. Most recent clinical characteristics of the four individuals described in this case series.

Individual	A-II-1	A-II-2	B-II-1	C-II-2
Sex	M	F	F	F
Age at follow-up (years)	14	12	18	11
BCVA  (OD, OS)	20/20, 20/20	20/20, 20/32	20/40, LP	CF, 20/63
SE (D)  (OD, OS)	+0.50, −0.50	−2.0, −3.75,	+1.25 (aphakic), na	−22.5, −3.25
CCT (µm)  (OD, OS)	594, 581	524, 527	632, 681	na
IOP (mmHg; OD, OS)	28, 21	16, 13	17, 9	6, 11
CC (D)  (OD, OS)	42.6/44.1, 43.0/43.8	44.8/45.9, 44.1/46.2	na	na
AL (mm; OD, OS)	na	na	31.48, 31.61	27.30, 23.01
ACD (mm)  (OD, OS)	4.55, 4.90^a	4.26, 4.19^a	na	na
Ectopia lentis	OD	OU^b	OU	OD
PPM	OU	OU	-	-
Iris TID	OU	OU	-	-
Spherophakia	OU	OU	-	-
Iris processes	OS	-	-	-
RD	-	-	OS	-
Lensectomy	-	-	OU	-
Glaucoma	-	-	OD^c	-
Systemic features	-	Learning difficulties, mild eczema, fructose and lactose intolerance	Motor delay, hypermobility, depression, anxiety, ASD	Learning difficulties, low vitamin D, ASD

M: male; F: female; BCVA: best-corrected visual acuity; OD: right eye; OS; left eye; LP: light perception; CF: count fingers; SE: spherical equivalent; D: diopters; na: not available; CCT: central corneal thickness; IOP: intraocular pressure; CC: corneal curvature; AL: axial length; ACD: anterior chamber depth; OU: both eyes; PPM: persistent pupillary membrane; TID: transillumination defect; RD: retinal detachment; ASD: autism spectrum disorder. ^aOcular surgery was not performed on these individuals ^bIndividual A-II-2 had phacodonesis; a preceding sign of ectopia lentis ^cIndividual B-II-1 had aphakic glaucoma (i.e., glaucoma onset followed lensectomy)